NRGEX | WSCGX | NRGEX / WSCGX | |
Total Expense Ratio | 0.03 | 0.94 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 1.04 | 66% |
Fund Existence | 4 years | 18 years | - |
Gain YTD | -3.342 | 4.213 | -79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.69B | 535M | 1,623% |
Annual Yield % from dividends | 0.54 | 0.00 | - |
Returns for 1 year | -9.46 | -9.99 | 95% |
Returns for 3 years | 8.17 | 3.61 | 226% |
Returns for 5 years | N/A | -41.09 | - |
Returns for 10 years | N/A | -15.04 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 75.60 | 0.47 | +0.63% |
Janus Henderson Global Life Sciences N | |||
GMCUX | 16.77 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
RLEFX | 38.98 | 0.04 | +0.10% |
American Funds American Balanced R5E | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst | |||
TAISX | 13.83 | -0.09 | -0.65% |
Nuveen Quant Intl Small Cap Eq I |